^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-CD56-CAR-T

    i
    Other names: anti-CD56-CAR-T
    Associations

    News

    Trials
    Company:
    Affiliated Hospital of Xuzhou Medical University
    Drug class:
    CD56-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia (clinicaltrials.gov)
    P2, N=20, Recruiting, The Affiliated Hospital of Xuzhou Medical University
    New P2 trial
    |
    IL6 (Interleukin 6) • NCAM1 (Neural cell adhesion molecule 1) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    cyclophosphamide • anti-CD56-CAR-T